Science Explorer Interactive view Map
Company · Rueil-Malmaison · France

Bristol-Myers Squibb (France)

In research, Bristol-Myers Squibb (France) stands highest in Medicine (#12,531 of 17,978 worldwide) and Health Sciences (#15,648 of 20,462 worldwide), over all time.

bmsfrance.fr/Pages/Home.aspxROR OpenAlex
World rank, all time
#26,995
of 42,892
Rank in France
#1,580
of 2,321
Research works
228
▼ 13% vs 2013–17
Citations
3.1k
13.7 per fractional work
Top-10% rate
10.8%
record average 16.5%
Open access
31%
world 28%

What is Bristol-Myers Squibb (France) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
MedicineField #12,531 of 17,978 14.1%128
Health SciencesDomain #15,648 of 20,462 14.0%137

Each strip is that field’s whole ranked pool, with the notch where Bristol-Myers Squibb (France) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 0.53× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 1.26× its world share, 0 worksImmunology and Micro…Neuroscience: 0.09× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.95× its world share, 0 worksPharmacology, Toxico…Computer Science: 0.03× its world share, 0 worksComputer ScienceEnvironmental Science: 0.10× its world share, 0 worksEnvironmental ScienceMathematics: 1.62× its world share, 1 worksMathematicsHealth Professions: 1.86× its world share, 2 worksHealth ProfessionsMedicine: 3.09× its world share, 19 worksMedicineVeterinary: 3.04× its world share, 0 worksVeterinaryArts and Humanities: 0.27× its world share, 0 worksArts and HumanitiesDecision Sciences: 1.30× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 11.27× its world share, 8 worksEconomics, Econometr…Psychology: 0.08× its world share, 0 worksPsychologySocial Sciences: 0.13× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Economics, Econometrics and Finance, 11.3×. Every wedge is a field page.

Who are the top researchers at Bristol-Myers Squibb (France)?

Ranked on the composite score, Anne-Françoise Gaudin, B. Bregman and Manuela Le Bars lead among researchers whose main affiliation is Bristol-Myers Squibb (France).

  1. 1 Anne-Françoise Gaudin France · #819,951 worldwide 29 citations · 21 works
  2. 2 B. Bregman France · #1,077,127 worldwide 11 citations · 15 works
  3. 3 Manuela Le Bars France · #1,323,946 worldwide 16 citations · 15 works
  4. 4 FE Cotté France · #1,368,604 worldwide 18 citations · 19 works
  5. 5 Alexandre Vainchtock France · #1,432,110 worldwide 3 citations · 21 works
  6. 6 S Roze France · #1,546,966 worldwide 3 citations · 22 works
  7. 7 M. Chartier France · #1,548,853 worldwide 5 citations · 15 works
  8. 8 François-Emery Cotté France · #1,551,013 worldwide 13 citations · 23 works
  9. 9 A.F. Gaudin France · #1,564,436 worldwide 3 citations · 21 works
All ranked researchers at Bristol-Myers Squibb (France)

Which keywords describe research at Bristol-Myers Squibb (France)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Cost of Care, Financial Toxicity, Chemotherapy, Quality of Life, Tumor Microenvironment, Cost-effectiveness Analysis, Health Utility Measures and Immunotherapy.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 30 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 30 words, with their numbers
  1. Cost of Care4▲ 382×1 topic
  2. Financial Toxicity4▲ 382×1 topic
  3. Chemotherapy3▲ 15×10 topics
  4. Quality of Life3▲ 6.9×5 topics
  5. Tumor Microenvironment3▲ 19×6 topics
  6. Cost-effectiveness Analysis3▲ 96×1 topic
  7. Health Utility Measures3▲ 96×1 topic
  8. Immunotherapy3▲ 11×8 topics
  9. Immune Checkpoint Blockade2▲ 70×1 topic
  10. PD-1 and PD-L12▲ 70×1 topic
  11. Cancer Survivorship2▲ 85×2 topics
  12. Epidemiology2▲ 1.46×14 topics
  13. Neoadjuvant Therapy2▲ 23×5 topics
  14. Molecular Characterization2▲ 30×4 topics
  15. Multiple Primary Cancers2▲ 254×1 topic
  16. Second Primary Neoplasms2▲ 254×1 topic
  17. Guidelines2▲ 9.9×3 topics
  18. Clinical Trials1▲ 6.2×7 topics
  19. Primary Care1▲ 10×3 topics
  20. Prognostic Factors1▲ 9.2×7 topics
  21. Healthcare Policy1▲ 39×2 topics
  22. Healthcare Quality Indicators1▲ 65×2 topics
  23. Public Health1▲ 2.6×2 topics
  24. Bladder Cancer1▲ 92×1 topic
  25. Inequalities1▲ 99×1 topic
  26. Lymphoma1▲ 21×3 topics
  27. Targeted Therapy1▲ 15×5 topics
  28. Treatment1▲ 2.7×9 topics
  29. Universal Health Coverage1▲ 99×1 topic
  30. Urothelial Carcinoma1▲ 79×1 topic

Which research topics does Bristol-Myers Squibb (France) publish most on?

By volume in 2022–2025: Economic and Financial Impacts of Cancer, Health Systems, Economic Evaluations, Quality of Life, Cancer Immunotherapy and Biomarkers and Multiple and Secondary Primary Cancers.

Economic and Financial I…4Economic and Financial Impacts of Cancer: 4 fractional worksHealth Systems, Economic Evaluations, Quality of Life: 3 fractional worksCancer Immunotherapy and Biomarkers: 2 fractional worksMultiple and Secondary Primary Cancers: 2 fractional worksBladder and Urothelial Cancer Treatments: 1 fractional worksHealthcare Systems and P…1Healthcare Systems and Practices: 1 fractional worksPharmaceutical Economics and Policy: 1 fractional worksColorectal Cancer Treatments and Studies: 1 fractional worksLung Cancer Treatments and Mutations: 1 fractional worksCAR-T cell therapy research: 1 fractional works
Economics and EconometricsOncologyEpidemiologySurgery2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Economic and Financial Impacts of Cancer Economics and Econometrics 4 works
  2. 2 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 3 works
  3. 3 Cancer Immunotherapy and Biomarkers Oncology 2 works
  4. 4 Multiple and Secondary Primary Cancers Epidemiology 2 works
  5. 5 Bladder and Urothelial Cancer Treatments Surgery 1 works
  6. 6 Healthcare Systems and Practices General Health Professions 1 works
  7. 7 Pharmaceutical Economics and Policy Economics and Econometrics 1 works
  8. 8 Colorectal Cancer Treatments and Studies Oncology 1 works
  9. 9 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 1 works
  10. 10 CAR-T cell therapy research Oncology 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available30.8%not open69.2%

World: 28% of research is openly available.

with international co-authors49.5%domestic only50.5%

World: 19% is written across borders.

How has Bristol-Myers Squibb (France)'s research output changed?

Output in 2018–2022 was 13% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Rueil-Malmaison

All research institutions in Rueil-Malmaison

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.